2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$46.08-$0.14 (-0.31%)
Price as of Oct 22, 2026 7:30 PM EDT- $3.7BMarket Cap
- 33.01%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$46.08-$0.14 (-0.31%)
VCYT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.22 | ||
Change | +$1.43 (+3.19%) | ||
Open | $44.17 | ||
High | $46.43 | ||
Low | $43.90 | ||
Previous Close | $44.79 | ||
Volume | 812,328 | ||
30-Day Average Volume | 1,358,739 | ||
1-Week Change | 6.23% | ||
1-Month Change | 11.32% | ||
1-Year Change | 33.01% | ||
3-Year Change | 120.83% | ||
5-Year Change | -0.67% | ||
Fundamentals | |||
Shares Outstanding | 80.4M | ||
Total Assets | $1.5B | ||
Market Cap | $3.7B | ||
Enterprise Value | $3.4B | ||
Period: QTR TTM FY | |||
Revenue | $145.7M | ||
Net Income | $25.5M | ||
Free Cash Flow | $43.0M | ||
EBIT | $26.5M | ||
EBITDA | $31.4M | ||
Net Working Capital | $512.0M | ||
EPS | $0.31 | ||
Enterprise Value/EBITDA | 109 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 3 | ||
P/E | 149 | ||
PEG | -13 | ||
Price/Free Cash Flow | 86 | ||
Price/Operating Cash Flow | 81 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue